Literature DB >> 2462321

Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma.

S I Yeoh1, R C Baxter.   

Abstract

This study examines the regulation of circulating GH-independent insulin-like growth factor binding protein, BP-28. Commencing at 22.00 h, BP-28 in 5 normal adults rose 11-fold to peak values of 120 +/- 12 micrograms/l, remained elevated between 01.00 and 08.00 h, then fell rapidly following a meal. If meals were omitted, BP-28 remained at peak levels throughout the day. The fasting BP-28 level was higher in women (141 +/- 22 micrograms/l, N = 5) than men (59 +/- 14 micrograms/l, N = 7), and pregnancy caused a further 2-fold elevation. Oral glucose rapidly lowered BP-28 in diabetic and nondiabetic pregnant women, nonpregnant women, and men. In a heterogeneous group of 18 subjects, insulin (0.1 U/kg iv), with or without simultaneous administration of GnRH and TRH, elicited a 3- to 4-fold rise in BP-28, commencing 60 min after the nadir of plasma glucose, and independent of the response in GH, PRL, TSH, LH or cortisol. We conclude that BP-28 levels in adults are metabolically regulated, and postulate a role for this protein in the maintenance of glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2462321     DOI: 10.1530/acta.0.1190465

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  11 in total

Review 1.  Insulin-like growth factors in central nervous system tumors.

Authors:  R P Glick; T Lichtor; T G Unterman
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

2.  A unique receptor-independent mechanism by which insulinlike growth factor I regulates the availability of insulinlike growth factor binding proteins in normal and transformed human fibroblasts.

Authors:  C A Conover
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

3.  Differential expression of insulin-like growth factor-I and insulin-like growth factor binding protein-1 in the diabetic rat.

Authors:  J M Luo; L J Murphy
Journal:  Mol Cell Biochem       Date:  1991-04-24       Impact factor: 3.396

4.  Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.

Authors:  P D Zenobi; S Graf; H Ursprung; E R Froesch
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

5.  Intraperitoneal fat and insulin resistance in obese adolescents.

Authors: 
Journal:  Obesity (Silver Spring)       Date:  2009-08-27       Impact factor: 5.002

Review 6.  The current status of IGF-I assays--a 2009 update.

Authors:  Jan Frystyk; Pamela Freda; David R Clemmons
Journal:  Growth Horm IGF Res       Date:  2009-10-08       Impact factor: 2.372

7.  Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.

Authors:  W H Daughaday; M Kapadia
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women.

Authors:  Moira S Lewitt; Agneta Hilding; Kerstin Brismar; Suad Efendic; Claes-Göran Ostenson; Kerstin Hall
Journal:  Eur J Endocrinol       Date:  2010-05-27       Impact factor: 6.664

9.  Impact of insulin resistance on insulin-like growth factor-1/insulin like growth factor-binding protein-3 axis and on early weight gain in small for gestational age infants.

Authors:  Ceyhun Dizdarer; Hüseyin Anıl Korkmaz; Özlem Murat Büyükocak; Selda Mohan Tarancı; Ayşe Coban
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013

10.  Insulin-Like Growth Factor-1 and Selected Insulin-Like Growth Factor Binding Protein Concentrations during an Ultramarathon Sled Dog Race.

Authors:  Matthew W Brunke; Christopher W Frye; Corri B Levine; Cristina Hansen; Joseph J Wakshlag
Journal:  ScientificWorldJournal       Date:  2016-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.